96623-75-5 Usage
Description
1-(2-FLUORO-5-NITROPHENYL)-1H-PYRROLE, with the molecular formula C11H7FN2O2, is an aromatic chemical compound characterized by a pyrrole ring and a nitro group attached to the phenyl ring. This unique molecular structure endows it with potential biological activities and electronic properties, making it a compound of interest in various fields.
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
1-(2-FLUORO-5-NITROPHENYL)-1H-PYRROLE is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its application is driven by its potential biological activities, which make it a valuable component in the development of new drugs and pesticides.
Used in Materials Science:
In the field of materials science, 1-(2-FLUORO-5-NITROPHENYL)-1H-PYRROLE is used as a building block for the development of novel materials. The presence of the fluorine and nitro groups in its molecule contributes to its utility in research and development, potentially leading to advancements in material properties and applications.
Used in Organic Electronics:
The unique electronic properties of 1-(2-FLUORO-5-NITROPHENYL)-1H-PYRROLE also make it a candidate for use in the field of organic electronics. Its molecular structure allows for potential applications in the development of organic electronic devices, such as organic light-emitting diodes (OLEDs) and organic photovoltaics (OPVs), where its electronic properties can be harnessed for improved performance and functionality.
Check Digit Verification of cas no
The CAS Registry Mumber 96623-75-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,6,2 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 96623-75:
(7*9)+(6*6)+(5*6)+(4*2)+(3*3)+(2*7)+(1*5)=165
165 % 10 = 5
So 96623-75-5 is a valid CAS Registry Number.
96623-75-5Relevant articles and documents
PROTEIN KINASE C INHIBITORS AND USES THEREOF
-
Page/Page column 34-35, (2010/08/07)
This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to ph
